TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|
Cash flow from operating activities | |||
Earning before tax | 36.57%1.88B | 14.10%1.38B | --1.21B |
Profit adjustment | |||
Interest (income) - adjustment | -30.18%-193.58M | 16.95%-148.7M | ---179.05M |
Investment loss (gain) | 8.64%-63.55M | -528.92%-69.56M | ---11.06M |
Impairment and provisions: | -149.55%-7.09M | 174.96%14.31M | ---19.09M |
-Other impairments and provisions | -149.55%-7.09M | 174.96%14.31M | ---19.09M |
Asset sale loss (gain): | 311.29%13.84M | -50.37%3.37M | --6.78M |
-Loss (gain) on sale of property, machinery and equipment | 311.29%13.84M | -50.37%3.37M | --6.78M |
Depreciation and amortization: | 44.58%446.87M | 22.50%309.08M | --252.31M |
-Other depreciation and amortization | -1.86%-16.97M | 16.02%-16.66M | ---19.84M |
Financial expense | 2,529.31%42.52M | -9.26%1.62M | --1.78M |
Operating profit before the change of operating capital | 42.54%2.12B | 18.16%1.49B | --1.26B |
Change of operating capital | |||
Inventory (increase) decrease | 221.09%210.74M | -8.62%-174.03M | ---160.22M |
Accounts receivable (increase)decrease | 17.03%-62.82M | 32.21%-75.72M | ---111.69M |
Accounts payable increase (decrease) | -663.83%-19.83M | -101.22%-2.6M | --213.17M |
Special items for working capital changes | -382.23%-107.31M | -122.46%-22.25M | --99.07M |
Cash from business operations | 76.58%2.14B | -6.67%1.21B | --1.3B |
Other taxs | -14.76%-420.05M | 22.18%-366.01M | ---470.32M |
Net cash from operations | 103.35%1.72B | 2.14%844.93M | --827.19M |
Cash flow from investment activities | |||
Interest received - investment | 135.15%121.27M | 24.40%51.57M | --41.45M |
Loan receivable (increase) decrease | 348.35%3.55B | -4.99%792.11M | --833.71M |
Decrease in deposits (increase) | -4,057.16%-3.52B | -1,341.87%-84.75M | --6.82M |
Sale of fixed assets | 268.51%8.45M | -7.35%2.29M | --2.48M |
Purchase of fixed assets | -211.37%-2.25B | -129.72%-722.89M | ---314.68M |
Purchase of intangible assets | 55.40%-60.87M | ---136.46M | ---- |
Acquisition of subsidiaries | ---- | --35K | ---- |
Recovery of cash from investments | -43.34%5.86B | 158.03%10.35B | --4.01B |
Cash on investment | 43.59%-5.8B | -157.07%-10.28B | ---4B |
Other items in the investment business | ---- | -67.95%32.41M | --101.11M |
Net cash from investment operations | -171,168.00%-2.09B | -99.82%1.22M | --681.95M |
Net cash before financing | -144.00%-372.27M | -43.93%846.15M | --1.51B |
Cash flow from financing activities | |||
New borrowing | --5.9B | ---- | ---- |
Refund | -36,874,937.50%-5.9B | 68.00%-16K | ---50K |
Interest paid - financing | -2,529.31%-42.52M | 9.26%-1.62M | ---1.78M |
Issuance expenses and redemption of securities expenses | ---1.05M | ---- | ---- |
Net cash from financing operations | -185.83%-60.6M | -8.91%-21.2M | ---19.47M |
Effect of rate | 48.06%-67K | -108.78%-129K | --1.47M |
Net Cash | -152.47%-432.87M | -44.62%824.95M | --1.49B |
Begining period cash | 49.01%2.51B | 778.01%1.68B | --191.66M |
Cash at the end | -17.26%2.07B | 49.01%2.51B | --1.68B |
Cash balance analysis | |||
Currency Unit | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Auditor | Deloitte Guan Huang Chen Fang Certified Public Accountants | Deloitte Guan Huang Chen Fang Certified Public Accountants | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.